NP47818 Glatiramer Injection

A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£500K
Sector
HEALTH
Published
08 Jul 2022
Delivery
not specified
Deadline
n/a

Related Terms

Location

All entities constituted pursuant to NHS (Scotland) Act 1978, any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014 and HSC Trusts in Northern Ireland

Geochart for 1 buyers and 2 suppliers

1 buyer

2 suppliers

Description

The Framework Agreement is for the supply of Glatiramer Acetate Injection in 20mg and 40mg presentations to NHS Scotland. Supply will be made either directly to hospitals, patients in their own homes, or other designated delivery address, via a manufactured commissioning Home Delivery Service or to a home delivery supplier(s) as directed by the Participating Authorities and/or the Authority.

Lot Division

1 Glatiramer Acetate Injection including the provision of a manufacturer commissioned Home Delivery Service

This Lot is for the supply of 20mg and 40mg Glatiramer Acetate Injection direct to hospitals or direct to patients in their own home, or other designated address, via a manufacturer commissioned Home Delivery Service.

2 Glatiramer Acetate Injection excluding a manufacturer commissioning Home Delivery Service

This Lot is for the supply of 20mg and 40mg glatiramer acetate injection direct to hospitals or nominated Home Delivery supplier(s) as directed by Participating Authorities and/or the Authority.

Award Detail

1 Mylan (Hatfield)
  • Glatiramer Acetate Injection excluding a manufacturer commissioning Home Delivery Service
  • Reference: 018779-2022-1
  • Value: £500,243
2 Teva (Castleford)
  • Glatiramer Acetate Injection including the provision of a manufacturer commissioned Home Delivery Service
  • Reference: 018779-2022-2
  • Value: £500,243

CPV Codes

  • 33600000 - Pharmaceutical products
  • 33661000 - Medicinal products for the nervous system

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value(s) referred to in Section II.I.7 and Section V2.4 covers the six(6) month modification period of the framework agreement. (SC Ref:699178)

Reference

  • ocds-h6vhtk-02f9a0
  • FTS 018779-2022

Domains